HIV/AIDS

Projected HIV and Bacterial Sexually Transmitted Infection Incidence Following COVID-19–Related Sexual Distancing and Clinical Service Interruption

1. Samuel M Jenness
2. Adrien Le Guillou
3. Christina Chandra
4. Laura M Mann
5. Travis Sanchez
6. Daniel Westreich
7. Julia L Marcus

Reviewed by ScreenIT, Rapid Reviews Infectious Diseases

Changes in Sexual Behavior, PrEP Adherence, and Access to Sexual Health Services Because of the COVID-19 Pandemic Among a Cohort of PrEP-Using MSM in the South

1. Sanjana Pampati
2. Kayla Emrick
3. Aaron J. Siegler
4. Jeb Jones

Reviewed by ScreenIT

Incidence of and factors associated with SARS‐CoV‐2 infection among people living with HIV in Southern Spain after one year of pandemic

1. Marta Fernandez‐Fuertes
2. Anaïs Corma‐Gomez
3. Eva Torres
4. Elena Rodriguez‐Pineda
5. Ana Fuentes‐Lopez
6. Pilar Rincon
7. Nieves Fernandez
8. Federico Garcia
9. Samuel Bernal
10. Luis M. Real
11. Juan Macias
12. Juan A. Pineda

Reviewed by ScreenIT

Changes in HIV treatment differentiated care uptake during the COVID‐19 pandemic in Zambia: interrupted time series analysis

1. Youngji Jo
2. Sydney Rosen
3. Karla Therese L. Sy
4. Bevis Phiri
5. Amy N. Huber
6. Muya Mwansa
7. Hilda Shakwelele
8. Prudence Haimbe
9. Mpande M. Mwenechanya
10. Priscilla Lumano‐Mulenga
11. Brooke E. Nichols

Reviewed by ScreenIT

Association of HIV infection with outcomes among adults hospitalized with COVID-19

1. Matthew S. Durstenfeld
2. Kaiwen Sun
3. Yifei Ma
4. Fatima Rodriguez
5. Eric A. Secemsky
6. Rushi V. Parikh
7. Priscilla Y. Hsue

Reviewed by ScreenIT

The impact of disruptions due to COVID‐19 on HIV transmission and control among men who have sex with men in China

1. Ross D Booton
2. Gengfeng Fu
3. Louis MacGregor
4. Jianjun Li
5. Jason J Ong
6. Joseph D Tucker
7. Katherine ME Turner
8. Weiming Tang
9. Peter Vickerman
10. Kate M Mitchell

Reviewed by ScreenIT

Knowledge and Impact of COVID-19 on Middle-Aged and Older People living with HIV in Lima, Peru

1. Monica M. Diaz
2. Diego M. Cabrera
3. Marcela Gil-Zacarías
4. Valeria Ramírez
5. Manuel Saavedra
6. Cesar Cárcamo
7. Evelyn Hsieh
8. Patricia J. García

Reviewed by ScreenIT

The risks and benefits of providing HIV services during the COVID-19 pandemic

1. John Stover
2. Sherrie L. Kelly
3. Edinah Mudimu
4. Dylan Green
5. Tyler Smith
6. Isaac Taramusi
7. Loveleen Bansi-Matharu
8. Rowan Martin-Hughes
9. Andrew N. Phillips
10. Anna Bershteyn

Reviewed by ScreenIT

Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels compared to protease inhibitor-based therapy

1. Alexander O Pasternak
2. Jelmer Vroom
3. Neeltje A Kootstra
4. Ferdinand WNM Wit
5. Marijn de Bruin
6. Davide De Francesco
7. Margreet Bakker
8. Caroline A Sabin
9. Alan Winston
10. Jan M Prins
11. Peter Reiss
12. Ben Berkhout
13. The Co-morBidity in Relation to Aids (COBRA) Collaboration
14. P Reiss
15. FWNM Wit
16. J Schouten
17. KW Kooij
18. RA van Zoest
19. BC Elsenga
20. FR Janssen
21. M Heidenrijk
22. W Zikkenheiner
23. M van der Valk
24. NA Kootstra
25. T Booiman
26. AM Harskamp-Holwerda
27. I Maurer
28. MM Mangas Ruiz
29. AF Girigorie
30. J Villaudy
31. E Frankin
32. AO Pasternak
33. B Berkhout
34. T van der Kuyl
35. P Portegies
36. BA Schmand
37. GJ Geurtsen
38. JA ter Stege
39. M Klein Twennaar
40. CBLM Majoie
41. MWA Caan
42. T Su
43. K Weijer
44. PHLT Bisschop
45. A Kalsbeek
46. M Wezel
47. I Visser
48. HG Ruhé
49. C Franceschi
50. P Garagnani
51. C Pirazzini
52. M Capri
53. F Dall'Olio
54. M Chiricolo
55. S Salvioli
56. J Hoeijmakers
57. J Pothof
58. M Prins
59. M Martens
60. S Moll
61. J Berkel
62. M Totté
63. S Kovalev
64. M Gisslén
65. D Fuchs
66. H Zetterberg
67. A Winston
68. J Underwood
69. L McDonald
70. M Stott
71. K Legg
72. A Lovell
73. O Erlwein
74. N Doyle
75. C Kingsley
76. DJ Sharp
77. R Leech
78. JH Cole
79. S Zaheri
80. MMJ Hillebregt
81. YMC Ruijs
82. DP Benschop
83. D Burger
84. M de Graaff-Teulen
85. G Guaraldi
86. A Bürkle
87. T Sindlinger
88. M Moreno-Villanueva
89. A Keller
90. C Sabin
91. D de Francesco
92. C Libert
93. S Dewaele

• Curated by eLife

  Evaluation Summary:

  This study addresses how antiviral treatment regimens impact persistence of an HIV reservoir in individuals who are treated for a long period. The authors examine measures of viral reservoir to understand how different antiviral treatment regimens impact residual virus in HIV infection. They find that NNRTI-based treatments are associated with lower viral reservoirs and better viral suppression than PI-based regimens, suggesting they may have some advantage at reducing HIV levels long term.

  (This preprint has been reviewed by eLife. We include the public reviews from the reviewers here; the authors also receive private feedback with suggested changes to the manuscript. Reviewer #1 agreed to share their name with the authors.)

Reviewed by eLife